Liver disease in management and outcomes of European and Asian patients with atrial fibrillation: A report from two observational prospective registries - PubMed
4 hours ago
- #Oral Anticoagulation
- #Atrial Fibrillation
- #Liver Disease
- Liver disease (LD) was present in 3.3% of 15,681 atrial fibrillation (AF) patients in European and Asian registries.
- LD was associated with lower oral anticoagulant (OAC) prescription, especially in European patients compared to Asian patients.
- LD increased the risk of composite outcome (all-cause death and major adverse cardiovascular events) and major adverse cardiovascular events.
- Among LD patients, those not prescribed OAC had a higher risk of major adverse cardiovascular events, with no difference in major bleeding.
- No significant differences in outcomes were found between European and Asian cohorts regarding the impact of LD.